These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6274907)

  • 1. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin.
    Carey RM
    J Clin Endocrinol Metab; 1982 Feb; 54(2):463-9. PubMed ID: 6274907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II, and adrenocorticotropin.
    Malchoff CD; Hughes JM; Carey RM
    J Clin Endocrinol Metab; 1987 Jul; 65(1):203-7. PubMed ID: 3034955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic modulation of aldosterone secretion in the rat.
    Aguilera G; Catt KJ
    Endocrinology; 1984 Jan; 114(1):176-81. PubMed ID: 6317344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake.
    Gordon MB; Moore TJ; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1983 Feb; 56(2):340-5. PubMed ID: 6822640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of adrenocorticotropin in the cortisol and aldosterone responses to angiotensin II in conscious dogs.
    Brooks VL; Daneshvar L; Reid IA
    Endocrinology; 1988 Jan; 122(1):97-104. PubMed ID: 2826116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine inhibits the aldosterone response to upright posture.
    Malchoff CD; Hughes J; Sen S; Jackson S; Carey RM
    J Clin Endocrinol Metab; 1986 Jul; 63(1):197-201. PubMed ID: 3519647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine modulates sodium-dependent aldosterone responses to angiotensin II in humans.
    Drake CR; Carey RM
    Hypertension; 1984; 6(2 Pt 2):I119-23. PubMed ID: 6373591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of direct effect of dopamine on aldosterone secretion in vivo.
    Lun S; Espiner EA; Nicholls MG; Hart DS
    Endocrinology; 1983 Jan; 112(1):60-3. PubMed ID: 6847834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of angiotensin II in the aldosterone secretory response to adrenocorticotropin in sodium-restricted normal human subjects.
    Elias AN; Anderson GH; Streeten DH
    J Clin Endocrinol Metab; 1978 Aug; 47(2):401-4. PubMed ID: 233670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of atrial natriuretic factor on angiotensin II- and adrenocorticotropin-stimulated aldosterone secretion.
    Aguilera G
    Endocrinology; 1987 Jan; 120(1):299-304. PubMed ID: 3023030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of dopamine in nonmodulating hypertension.
    Gordon MS; Steunkel CA; Conlin PR; Hollenberg NK; Williams GH
    J Clin Endocrinol Metab; 1989 Aug; 69(2):426-32. PubMed ID: 2753983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine selectively inhibits aldosterone responses to angiotensin II in man.
    Carey RM; Drake CR
    J Hypertens Suppl; 1984 Dec; 2(3):S267-9. PubMed ID: 6100739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic suppression of angiotensin II-induced aldosterone secretion in man: differential responses during sodium loading and depletion.
    Drake CR; Ragsdale NV; Kaiser DL; Carey RM
    Metabolism; 1984 Aug; 33(8):696-702. PubMed ID: 6379373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished aldosterone responses to angiotensin II and adrenocorticotropin in hypocalcemic subjects: restoration of responsiveness with normocalcemia.
    Brickman AS; Trujillo AL; Gutin MS; Tuck ML
    J Clin Endocrinol Metab; 1987 Feb; 64(2):297-303. PubMed ID: 3025245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
    J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of metoclopramide and dopamine on plasma aldosterone concentration in normal man and rhesus monkeys (Macaca mulatta): a new model to study dopamine control of aldosterone secretion.
    Brown RD; Billman GE; Kem DC; Stone HL; Jiang NS; Kao P; Hegstad RL
    J Clin Endocrinol Metab; 1982 Nov; 55(5):828-32. PubMed ID: 7119085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
    Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
    Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.